Essentials of Hypertension : (Record no. 132909)
[ view plain ]
000 -LEADER | |
---|---|
fixed length control field | 06227nam a22004453i 4500 |
001 - CONTROL NUMBER | |
control field | EBC5152964 |
003 - CONTROL NUMBER IDENTIFIER | |
control field | MiAaPQ |
005 - DATE AND TIME OF LATEST TRANSACTION | |
control field | 20240729131611.0 |
006 - FIXED-LENGTH DATA ELEMENTS--ADDITIONAL MATERIAL CHARACTERISTICS | |
fixed length control field | m o d | |
007 - PHYSICAL DESCRIPTION FIXED FIELD--GENERAL INFORMATION | |
fixed length control field | cr cnu|||||||| |
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION | |
fixed length control field | 240724s2017 xx o ||||0 eng d |
020 ## - INTERNATIONAL STANDARD BOOK NUMBER | |
International Standard Book Number | 9783319632728 |
Qualifying information | (electronic bk.) |
020 ## - INTERNATIONAL STANDARD BOOK NUMBER | |
Canceled/invalid ISBN | 9783319632711 |
035 ## - SYSTEM CONTROL NUMBER | |
System control number | (MiAaPQ)EBC5152964 |
035 ## - SYSTEM CONTROL NUMBER | |
System control number | (Au-PeEL)EBL5152964 |
035 ## - SYSTEM CONTROL NUMBER | |
System control number | (CaPaEBR)ebr11472020 |
035 ## - SYSTEM CONTROL NUMBER | |
System control number | (OCoLC)1013825593 |
040 ## - CATALOGING SOURCE | |
Original cataloging agency | MiAaPQ |
Language of cataloging | eng |
Description conventions | rda |
-- | pn |
Transcribing agency | MiAaPQ |
Modifying agency | MiAaPQ |
050 #4 - LIBRARY OF CONGRESS CALL NUMBER | |
Classification number | RC666-701.2 |
082 0# - DEWEY DECIMAL CLASSIFICATION NUMBER | |
Classification number | 616.132 |
100 1# - MAIN ENTRY--PERSONAL NAME | |
Personal name | Fuchs, Flávio Danni. |
245 10 - TITLE STATEMENT | |
Title | Essentials of Hypertension : |
Remainder of title | The 120/80 Paradigm. |
250 ## - EDITION STATEMENT | |
Edition statement | 1st ed. |
264 #1 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE | |
Place of production, publication, distribution, manufacture | Cham : |
Name of producer, publisher, distributor, manufacturer | Springer International Publishing AG, |
Date of production, publication, distribution, manufacture, or copyright notice | 2017. |
264 #4 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE | |
Date of production, publication, distribution, manufacture, or copyright notice | ©2018. |
300 ## - PHYSICAL DESCRIPTION | |
Extent | 1 online resource (161 pages) |
336 ## - CONTENT TYPE | |
Content type term | text |
Content type code | txt |
Source | rdacontent |
337 ## - MEDIA TYPE | |
Media type term | computer |
Media type code | c |
Source | rdamedia |
338 ## - CARRIER TYPE | |
Carrier type term | online resource |
Carrier type code | cr |
Source | rdacarrier |
505 0# - FORMATTED CONTENTS NOTE | |
Formatted contents note | Intro -- Preface -- Acknowledgments -- Contents -- 1: Risks of High Blood Pressure and Goals for Treatment -- 1.1 Risks for Coronary Heart Disease, Stroke, and Cardiovascular Mortality -- 1.2 Other Risks of High Blood Pressure -- 1.2.1 Heart Failure -- 1.2.2 Aortic Valve Stenosis and other heart valve diseases -- 1.2.3 Atrial Fibrillation -- 1.2.4 Aortic Stiffness and Aortic Syndromes -- 1.2.5 Peripheral Arterial Disease -- 1.2.6 Chronic Kidney Disease -- 1.2.7 Dementias -- 1.2.8 Diabetes Mellitus -- 1.2.9 Age-Related Macular Degeneration -- 1.2.10 Erectile Dysfunction -- 1.3 Populations at Risk and Trends in High Blood Pressure -- 1.4 Diagnostic Thresholds: Recommendations from Hypertension Guidelines -- 1.5 Proof of Concept: Experimental Evidence -- 1.6 Goals for Treatment and the J-Shaped Phenomenon -- 1.7 SPRINT -- 1.8 Benefits of Treating Prehypertension -- 1.9 Low Blood Pressure: The Key to a Long and Healthier Life -- 1.10 Misconceptions and Lack of Action -- 1.11 Blood Pressure Classification -- References -- 2: Pathogenesis -- 2.1 Maladaptation to Sodium Overload -- 2.1.1 Epidemiological Evidence -- 2.1.2 Salt Sensitivity -- 2.1.3 The Central Role of the Kidneys in the Pathogenesis of Hypertension -- 2.1.4 Proof of Concept: The Role of Intrinsic Renal Capacity to Handle Salt Overload in the Pathogenesis of Hypertension -- 2.2 Excessive Adiposity -- 2.3 Diabetes and Metabolic Syndrome -- 2.4 Potassium and Other Dietary Factors -- 2.5 Alcohol, Hypertension, and Cardiovascular Disease -- 2.6 Sleep Disorders -- 2.7 Stress -- 2.8 Other Risks for Hypertension -- 2.8.1 Socioeconomic and Educational Risks -- 2.8.2 Depression -- 2.8.3 Oral Contraceptives -- 2.8.4 Shift Work -- 2.8.5 Endothelial Dysfunction -- 2.8.6 Oxidative Stress and Inflammation -- 2.8.7 Other Risks -- References. |
505 8# - FORMATTED CONTENTS NOTE | |
Formatted contents note | 3: Diagnosis and Evaluation -- 3.1 Blood Pressure Measurement -- 3.2 Daily Blood Pressure Load and the Concept of Casual and Usual Blood Pressure -- 3.3 Precision of Methods Used to Estimate Risks of High Blood Pressure -- 3.4 White-Coat and Masked Hypertension -- 3.4.1 Diagnostic Thresholds for Out-of-Office Blood Pressure Measurement -- 3.5 Clinical Evaluation -- 3.5.1 Headache -- 3.5.2 Epistaxis -- 3.5.3 Quality of Life -- 3.5.4 Musculoskeletal Complaints -- 3.5.5 Other Findings in the Medical History -- 3.5.6 Physical Examination -- 3.5.7 Laboratory Data -- 3.6 Risk Stratification -- 3.6.1 Electrocardiography -- 3.6.2 Echocardiography -- 3.6.3 Development of Clinical Disease -- 3.6.4 Optic Fundus Abnormalities -- 3.6.5 Aortic Stiffness and Peripheral Arterial Disease -- 3.7 Blood Pressure Variability -- 3.8 Resistant Hypertension -- 3.9 Secondary Hypertension -- References -- 4: Prevention and Treatment -- 4.1 Nonpharmacological Therapies -- 4.1.1 Reduction of Salt Intake -- 4.1.1.1 In Populations -- 4.1.1.2 In Individuals with Normal and High Blood Pressure -- 4.1.2 Hypocaloric Diet -- 4.1.3 DASH Diet -- 4.1.4 PREDIMED Diet -- 4.1.5 Supplementation of Potassium, Calcium, and Magnesium -- 4.1.6 Comparative Effectiveness of Dietary Interventions -- 4.1.7 Other Nutritional Interventions -- 4.1.7.1 Alcoholic Beverage Consumption -- 4.1.7.2 Chocolate and Other Cocoa Products -- 4.1.7.3 Other Nutraceuticals -- 4.1.7.4 Probiotics -- 4.1.8 Physical Activity -- 4.1.9 Treatment of Obstructive Sleep Apnea as a Means to Treat Hypertension -- 4.1.10 Oral Contraceptives and Hormone Replacement Therapy -- 4.1.11 Surgical Treatment of Hypertension -- 4.1.11.1 Renovascular Hypertension -- 4.1.11.2 Renal Sympathetic Denervation -- 4.1.11.3 Bariatric Surgery -- 4.1.12 Other Nonpharmacological Treatments. |
505 8# - FORMATTED CONTENTS NOTE | |
Formatted contents note | 4.1.12.1 Behavioral Therapies -- 4.1.12.2 Acupuncture -- 4.1.12.3 Device-Guided Breathing Modulation -- 4.2 Drug Treatment -- 4.2.1 Pioneering Studies -- 4.2.2 The First Choice -- 4.2.3 Diuretic Preference and Association with Potassium-Sparing Agents -- 4.2.4 Other Options for the First Choice -- 4.2.5 Second-Line and Third-Line Drugs for Management of Hypertension -- 4.2.6 Management of Resistant Hypertension -- 4.2.7 Adverse Events, Adverse Effects, and the Nocebo Effect -- 4.2.8 Hypertensive Crises, Urgencies, and Emergencies -- 4.2.9 Strategies to Improve Adherence to Treatment -- 4.2.9.1 Self-Monitoring of Blood Pressure -- 4.2.9.2 Telemonitoring -- 4.2.9.3 Pharmacist Care -- 4.2.9.4 Text Messages -- References -- Erratum to: Diagnosis and Evaluation -- Index. |
588 ## - SOURCE OF DESCRIPTION NOTE | |
Source of description note | Description based on publisher supplied metadata and other sources. |
590 ## - LOCAL NOTE (RLIN) | |
Local note | Electronic reproduction. Ann Arbor, Michigan : ProQuest Ebook Central, 2024. Available via World Wide Web. Access may be limited to ProQuest Ebook Central affiliated libraries. |
650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Hypertension. |
655 #4 - INDEX TERM--GENRE/FORM | |
Genre/form data or focus term | Electronic books. |
776 08 - ADDITIONAL PHYSICAL FORM ENTRY | |
Relationship information | Print version: |
Main entry heading | Fuchs, Flávio Danni |
Title | Essentials of Hypertension |
Place, publisher, and date of publication | Cham : Springer International Publishing AG,c2017 |
International Standard Book Number | 9783319632711 |
797 2# - LOCAL ADDED ENTRY--CORPORATE NAME (RLIN) | |
Corporate name or jurisdiction name as entry element | ProQuest (Firm) |
856 40 - ELECTRONIC LOCATION AND ACCESS | |
Uniform Resource Identifier | <a href="https://ebookcentral.proquest.com/lib/orpp/detail.action?docID=5152964">https://ebookcentral.proquest.com/lib/orpp/detail.action?docID=5152964</a> |
Public note | Click to View |
No items available.